As of November 6, 2026, Amgen Inc. is a publicly traded company (Nasdaq: AMGN); its largest reported holder is Vanguard, with 7.51% on Schedule 13G of April 29, 2026, then Capital World Investors (5.5%). The largest insider holding is Robert A. Bradway, the chairman and chief executive, with 655,220 shares (0.12% of shares outstanding), per Form 4 of May 11, 2026 (Schedule 13G, April 29, 2026).
Is this your company?
About to sign with, pay or invest in Amgen Inc.? See the free Snapshot first.
Free to see. No signup.
Is Amgen Inc. a real, registered company?
- Amgen Inc. files with the SEC under CIK 318154 (its SEC filings).
- Its shares are listed under the ticker AMGN on Nasdaq (SEC company record).
- Incorporated in Delaware; business address in Thousand Oaks, California, as its SEC filings state.
- Court and bankruptcy records: see Before you sign or pay below.
Before you sign or pay
- Court and bankruptcy: No federal court case or bankruptcy filing found under Amgen Inc. in our court records and SEC 8-K records (as of 2026-11-06).
- Leadership changes: the latest reported is David W. Gibbs, Director (Form 8-K filed 2026-10-27). Check you are dealing with the people now in charge.
- Ownership: 5%+ holders are reported on Schedule 13D or 13G; the latest names Capital World Investors (filed 2026-05-14).
Who are Amgen Inc.'s owners and officers?
Amgen Inc.: incorporated in Delaware; business address in Thousand Oaks, California; industry Biological Products, (No Diagnostic Substances) (Form D, 2026-10-27).
| Report | Holder | Share |
|---|---|---|
| Schedule 13G, 2026-05-14 | Capital World Investors | 5.5% |
| Schedule 13G, 2026-04-29 | Vanguard Capital Management | 7.51% |
| Schedule 13G/A, 2026-03-26 | The Vanguard Group | 0% |
| Schedule 13G/A, 2025-09-08 | The Vanguard Group | 10% |
Questions about who owns Amgen Inc.
Who owns Amgen Inc.?
On this page, 2 holders' latest ownership filings report 5% or more of Amgen Inc.: Vanguard Capital Management (7.51%, Schedule 13G, filed 2026-04-29) and Capital World Investors (5.5%, Schedule 13G, filed 2026-05-14).
Who are the largest shareholders of Amgen Inc.?
By the share each holder's latest filing reports, the largest holders of Amgen Inc. on this page are Vanguard Capital Management (7.51%) and Capital World Investors (5.5%).
When did Vanguard Capital Management buy into Amgen Inc.?
The filings give report dates, not purchase dates. The earliest filing from Vanguard Capital Management on this page is the Schedule 13G, filed 2026-04-29, reporting 7.51%.
Is this an audit or a full list?
Neither. The ownership list on this page covers only Schedule 13D and 13G filings, which holders make once they own 5% or more of a class of shares (an amendment can report a stake that has since fallen below 5%); 4 such filings are shown here. It is not an audit and not a full cap table: holders who never reached 5% are not listed, and a stake can change after its latest filing.
Want the whole picture on Amgen Inc.?
Example from a real report (our sample on Target): “Target eliminated approximately 1,800 corporate positions, with around 1,000 employees receiving layoff notices and the remainder accounted for by eliminating open roles.” Source: NBC News
A Full Report on Amgen Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Amgen Inc. covers
The Short Answer
Which Company This Is
What They Do, And How The Money Works
Who Runs It, And How To Reach Them
The Money: Funding, Valuation, Runway
Who Pays Them, And Who They Are Up Against
Warning Bells
Sources
13 cited sources found
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
| Filed | Person | Role | Change | Effective |
|---|---|---|---|---|
| Form 8-K, 2026-10-27 | David W. Gibbs | Director | appointed | |
| Form 8-K, 2026-05-19 | Peter H. Griffith | Chief Financial Officer | departed | 2026-08-31 |
| Form 8-K, 2026-04-22 | David M. Reese | Executive Vice President | departed |
Which insiders own Amgen Inc. shares?
Directors, officers and holders of 10% or more report their shares on Forms 3, 4 and 5. Each line is the latest such report, largest holding first.
- , the chairman and chief executive: 655,220 shares (0.12% of shares outstanding), 505,160 held directly and 150,060 indirectly (Form 4, 2026-05-11).
- , the executive vice president and operations: 83,756.99 shares (0.02% of shares outstanding), 82,847 held directly and 909.99 indirectly (Form 4, 2026-05-11).
- , the executive vice president and global commercial operations: 51,222 shares (0.01% of shares outstanding) (Form 4, 2026-05-11).
- , the chief financial officer and executive vice president: 50,150 shares (0.01% of shares outstanding) (Form 4, 2026-05-11).
- , the chief technology officer and executive vice president: 42,256 shares (0.01% of shares outstanding) (Form 4, 2026-05-11).
Shares outstanding: 540,911,490 as of 2026-10-29, from the company's latest SEC cover page.
How much has Amgen Inc. raised?
No fundraising or offering filing from Amgen Inc. is on file with us.
Keep reading
More on Amgen Inc. and the records around it.
Amgen Inc. elsewhere on the record
- Leadership changes May 2026
Companies that share a holder
- Capital World Investors also filed stake reports on 125 other companies: New Fortress Energy Inc. (Oct 2026), Aura Minerals Inc. (Oct 2026), Skyworks Solutions, Inc. (Oct 2026)
- Vanguard Capital Management also filed stake reports on 1495 other companies: A10 Networks Inc (Oct 2026), Altisource Portfolio Solutions SA (Oct 2026), Alto Neuroscience Inc (Oct 2026)
- The Vanguard Group also filed stake reports on 2384 other companies: BellRing Brands, Inc. (Sep 2026), CAL-MAINE FOODS INC (Sep 2026), FTAI Aviation Ltd. (Sep 2026)
Related pages
Filings, cases and notices link to their records. A not-found line names the records searched; it is not proof of absence.
Not for employment, credit, insurance or tenancy decisions.
Cite this page
https://mentionfox.com/who-owns/amgen